A View LCS vs Viz RV/LV
AI Verdict
Choose A View LCS if…
Choose A View LCS if your clinical practice requires a comprehensive, multi-disease analysis from a single low-dose thoracic CT scan, encompassing detailed lung cancer screening, emphysema quantification, and coronary artery calcification scoring. This tool is ideal for proactive screening programs that benefit from automated, detailed quantification and reporting across multiple chronic thoracic conditions.
View A View LCS →Choose Viz RV/LV if…
Choose Viz RV/LV if your priority is rapid and automated risk stratification for suspected pulmonary embolism, specifically by obtaining crucial RV/LV ratio measurements from CTPA scans. This tool is best suited for emergency and acute care settings where immediate identification of ventricular strain and seamless integration into a broader pulmonary embolism care coordination workflow are critical for timely patient management.
View Viz RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | A View LCS | Viz RV/LV |
|---|---|---|
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). It can also be integrated into standard reading environments (PACS), RIS (Radiological Information System), or used as a standalone third-party application or web-based application. | Cloud-based |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz RV/LVViz RV/LV (Tool B) excels in usability by focusing on real-time clinical workflows, offering AI-powered alerts, a high-fidelity mobile DICOM viewer, and a HIPAA-compliant communication platform for seamless care coordination. Its emphasis on immediate actionability and integrated team communication, supported by dedicated customer success and 24/7 support, streamlines critical care pathways. While A View LCS (Tool A) provides comprehensive reporting and 3D visualization, Tool B's features are more directly aligned with enhancing the day-to-day operational efficiency and responsiveness of care teams.
Clinical Value
A View LCSA View LCS (Tool A) offers superior clinical value through its comprehensive thoracic CT analysis, detecting lung cancer, emphysema, and coronary artery calcification from a single low-dose CT scan. This multi-disease detection capability maximizes diagnostic efficiency and provides a broader range of critical insights from one examination. In contrast, Viz RV/LV (Tool B) is highly specialized, focusing on a single measurement for pulmonary embolism risk stratification, which, while important, is narrower in scope.
Pricing & Value
TieBoth A View LCS (Tool A) and Viz RV/LV (Tool B) require prospective customers to contact the vendor for pricing information, indicating a lack of public transparency. Without specific pricing details or publicly available comparative ROI studies for either product, it is impossible to definitively assess or compare their pricing and overall value propositions.
Enterprise Readiness
A View LCSA View LCS (Tool A) demonstrates greater enterprise readiness due to its flexible deployment options, including cloud-based, hybrid, local dedicated hardware, and local virtualized solutions. This versatility allows it to integrate more seamlessly into diverse IT infrastructures and accommodate varying data governance requirements of healthcare organizations. While Viz RV/LV (Tool B) is FDA-cleared, HIPAA compliant, and boasts extensive security certifications and a large customer base, its cloud-only deployment may not suit all enterprise needs.
Innovation
A View LCSA View LCS (Tool A) showcases innovation with its 'CT kernel conversion AI technology,' which standardizes image analysis across different CT acquisition parameters, and its ability to perform comprehensive multi-disease analysis from a single low-dose CT scan. This addresses fundamental challenges in imaging consistency and diagnostic efficiency. While Viz RV/LV (Tool B) innovates in care coordination and workflow optimization with features like AI-powered alerts and Viz Agent Studio, Tool A's core imaging analysis advancements are more foundational.
Support & Docs
Viz RV/LVViz RV/LV (Tool B) offers a more robust and transparent support framework, including 24/7/365 urgent phone support, a dedicated customer success team, a comprehensive Help Center, and a 'Viz Academy' for user training. This extensive support ecosystem ensures continuous assistance and user enablement. While Coreline Soft (Tool A) provides customer service contacts and expert consultations, Viz.ai's multi-channel, round-the-clock support and educational resources demonstrate a stronger commitment to ongoing user support and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | A View LCS | Viz RV/LV |
|---|---|---|
| Name | A View LCS | Viz RV/LV |
| Company | Coreline Soft Co. | Viz.ai |
| Description | AVIEW LCS by Coreline Soft is an FDA-cleared AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. | Viz RV/LV by Viz.ai is an FDA-cleared AI algorithm that automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution. |
| Categories | Cardiology AI, Oncology AI, Radiology & Imaging AI | Cardiology AI, Clinical Decision Support & Reference, Radiology & Imaging AI |
| Specialties | Cardiology, Pulmonology, Radiology | Emergency Medicine, Pulmonology, Radiology |
| Key Features | Automated lung nodule detection and classification; Nodule volume quantification and measurement (3D); Lung-RADS scoring and reporting; Emphysema analysis and quantification (LAA); Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass); Segmentation of major coronary arteries; Automated comprehensive report generation (PDF, DICOM PDF, SR); CT kernel conversion AI technology | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement; Analysis of volumetric CTPA acquisitions; AI algorithm for identification and measurement of heart ventricles; Provides annotated images showing ventricular measurements; Seamless component of the Viz PE Solution for suspected pulmonary embolism detection; AI-powered alerts and notifications to care teams; High-fidelity mobile DICOM image viewer; HIPAA-compliant communication platform for care coordination |
Videos
Demos, reviews, and walkthroughs featuring A View LCS and Viz RV/LV.